BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34948243)

  • 21. Genetic Diagnostic Evaluation of Trio-Based Whole Exome Sequencing Among Children With Diagnosed or Suspected Autism Spectrum Disorder.
    Du X; Gao X; Liu X; Shen L; Wang K; Fan Y; Sun Y; Luo X; Liu H; Wang L; Wang Y; Gong Z; Wang J; Yu Y; Li F
    Front Genet; 2018; 9():594. PubMed ID: 30555518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional DNA methylation signatures for autism spectrum disorder genomic risk loci: 16p11.2 deletions and CHD8 variants.
    Siu MT; Butcher DT; Turinsky AL; Cytrynbaum C; Stavropoulos DJ; Walker S; Caluseriu O; Carter M; Lou Y; Nicolson R; Georgiades S; Szatmari P; Anagnostou E; Scherer SW; Choufani S; Brudno M; Weksberg R
    Clin Epigenetics; 2019 Jul; 11(1):103. PubMed ID: 31311581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic analysis of intellectual disability and autism.
    Chiurazzi P; Kiani AK; Miertus J; Paolacci S; Barati S; Manara E; Stuppia L; Gurrieri F; Bertelli M
    Acta Biomed; 2020 Nov; 91(13-S):e2020003. PubMed ID: 33170170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three intellectual disability-associated de novo mutations in MECP2 identified by trio-WES analysis.
    Gu Y; Xiang B; Zhu L; Ma X; Chen X; Cai T
    BMC Med Genet; 2020 May; 21(1):99. PubMed ID: 32393352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurogenetic analysis of childhood disintegrative disorder.
    Gupta AR; Westphal A; Yang DYJ; Sullivan CAW; Eilbott J; Zaidi S; Voos A; Vander Wyk BC; Ventola P; Waqar Z; Fernandez TV; Ercan-Sencicek AG; Walker MF; Choi M; Schneider A; Hedderly T; Baird G; Friedman H; Cordeaux C; Ristow A; Shic F; Volkmar FR; Pelphrey KA
    Mol Autism; 2017; 8():19. PubMed ID: 28392909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Performance of a Dominant/X-Linked Gene Panel in Patients with Neurodevelopmental Disorders.
    Spataro N; Trujillo-Quintero JP; Manso C; Gabau E; Capdevila N; Martinez-Glez V; Berenguer-Llergo A; Reyes S; Brunet A; Baena N; Guitart M; Ruiz A
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted sequencing identifies risk variants in 202 candidate genes for neurodevelopmental disorders.
    Pang N; Li K; Tan S; Chen M; He F; Chen C; Yang L; Zhang C; Deng X; Yang L; Mao L; Wang G; Duan H; Wang X; Zhang W; Guo H; Peng J; Yin F; Xia K
    Gene; 2024 Mar; 897():148071. PubMed ID: 38081334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-genome sequencing in a family with twin boys with autism and intellectual disability suggests multimodal polygenic risk.
    McKenna B; Koomar T; Vervier K; Kremsreiter J; Michaelson JJ
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation gene panel testing in adolescents and adults in a medical neuropsychiatric genetics clinic.
    Trakadis Y; Accogli A; Qi B; Bloom D; Joober R; Levy E; Tabbane K
    Neurogenetics; 2021 Oct; 22(4):313-322. PubMed ID: 34363551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two de novo novel mutations in one SHANK3 allele in a patient with autism and moderate intellectual disability.
    Zhu W; Li J; Chen S; Zhang J; Vetrini F; Braxton A; Eng CM; Yang Y; Xia F; Keller KL; Okinaka-Hu L; Lee C; Holder JL; Bi W
    Am J Med Genet A; 2018 Apr; 176(4):973-979. PubMed ID: 29423971
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Chouery E; Makhlouf J; Daoud Khatoun W; Mehawej C; Megarbane A
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder.
    Mahjani B; De Rubeis S; Gustavsson Mahjani C; Mulhern M; Xu X; Klei L; Satterstrom FK; Fu J; Talkowski ME; Reichenberg A; Sandin S; Hultman CM; Grice DE; Roeder K; Devlin B; Buxbaum JD
    Mol Autism; 2021 Oct; 12(1):65. PubMed ID: 34615535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular investigation, using chromosomal microarray and whole exome sequencing, of six patients affected by Williams Beuren syndrome and Autism Spectrum Disorder.
    Masson J; Demily C; Chatron N; Labalme A; Rollat-Farnier PA; Schluth-Bolard C; Gilbert-Dussardier B; Giuliano F; Touraine R; Tordjman S; Verloes A; Testa G; Sanlaville D; Edery P; Lesca G; Rossi M
    Orphanet J Rare Dis; 2019 May; 14(1):121. PubMed ID: 31151468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic determinants of global developmental delay and intellectual disability in Ukrainian children.
    Shchubelka K; Turova L; Wolfsberger W; Kalanquin K; Williston K; Kurutsa O; Makovetska A; Hasynets Y; Mirutenko V; Vakerych M; Oleksyk TK
    J Neurodev Disord; 2024 Mar; 16(1):13. PubMed ID: 38539105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome Sequencing in 200 Intellectual Disability/Autistic Patients: New Candidates and Atypical Presentations.
    Valentino F; Bruno LP; Doddato G; Giliberti A; Tita R; Resciniti S; Fallerini C; Bruttini M; Lo Rizzo C; Mencarelli MA; Mari F; Pinto AM; Fava F; Baldassarri M; Fabbiani A; Lamacchia V; Benetti E; Zguro K; Furini S; Renieri A; Ariani F
    Brain Sci; 2021 Jul; 11(7):. PubMed ID: 34356170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exome sequencing reveals predominantly de novo variants in disorders with intellectual disability (ID) in the founder population of Finland.
    Järvelä I; Määttä T; Acharya A; Leppälä J; Jhangiani SN; Arvio M; Siren A; Kankuri-Tammilehto M; Kokkonen H; Palomäki M; Varilo T; Fang M; Hadley TD; Jolly A; Linnankivi T; Paetau R; Saarela A; Kälviäinen R; Olme J; Nouel-Saied LM; Cornejo-Sanchez DM; Llaci L; Lupski JR; Posey JE; Leal SM; Schrauwen I
    Hum Genet; 2021 Jul; 140(7):1011-1029. PubMed ID: 33710394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of an individual with a SYGNAP1 pathogenic mutation in India.
    Verma V; Mandora A; Botre A; Clement JP
    Mol Biol Rep; 2020 Nov; 47(11):9225-9234. PubMed ID: 33090308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing.
    Redin C; Gérard B; Lauer J; Herenger Y; Muller J; Quartier A; Masurel-Paulet A; Willems M; Lesca G; El-Chehadeh S; Le Gras S; Vicaire S; Philipps M; Dumas M; Geoffroy V; Feger C; Haumesser N; Alembik Y; Barth M; Bonneau D; Colin E; Dollfus H; Doray B; Delrue MA; Drouin-Garraud V; Flori E; Fradin M; Francannet C; Goldenberg A; Lumbroso S; Mathieu-Dramard M; Martin-Coignard D; Lacombe D; Morin G; Polge A; Sukno S; Thauvin-Robinet C; Thevenon J; Doco-Fenzy M; Genevieve D; Sarda P; Edery P; Isidor B; Jost B; Olivier-Faivre L; Mandel JL; Piton A
    J Med Genet; 2014 Nov; 51(11):724-36. PubMed ID: 25167861
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Roston A; Evans D; Gill H; McKinnon M; Isidor B; Cogné B; Mwenifumbo J; van Karnebeek C; An J; Jones SJM; Farrer M; Demos M; Connolly M; Gibson WT; ;
    J Med Genet; 2021 Mar; 58(3):196-204. PubMed ID: 32546566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and Epilepsy.
    Lumish HS; Wynn J; Devinsky O; Chung WK
    J Autism Dev Disord; 2015 Nov; 45(11):3764-70. PubMed ID: 26084711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.